These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity. Lwaleed BA; Francis JL; Chisholm M J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of an assay for urinary tissue factor activity. Lwaleed BA; Chisholm M; Francis JL J Clin Pathol; 1999 Mar; 52(3):219-24. PubMed ID: 10450183 [TBL] [Abstract][Full Text] [Related]
5. The estriol quotient in fibrocystic disease, a high-risk group for breast cancer. Bagli NP; Shah PN; Mistry SS Indian J Cancer; 1980 Dec; 17(4):201-4. PubMed ID: 7228103 [No Abstract] [Full Text] [Related]
6. Urinary tissue factor levels in patients with breast and colorectal cancer. Lwaleed BA; Chisholm M; Francis JL J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081 [TBL] [Abstract][Full Text] [Related]
7. [The role of the urinary hydroxyproline level in the screening for collagen diseases]. Gambella GR; Zunino M Minerva Med; 1986 Apr; 77(16):607-12. PubMed ID: 3703359 [TBL] [Abstract][Full Text] [Related]
8. Tryptophan metabolism in patients with breast cancer. Poulter JM; Dickerson JW; White WF Acta Vitaminol Enzymol; 1985; 7(1-2):93-7. PubMed ID: 4036762 [TBL] [Abstract][Full Text] [Related]
9. Urinary tissue factor: a potential marker of disease. Lwaleed BA; Bass PS; Francis JL J Pathol; 1999 May; 188(1):3-8. PubMed ID: 10398132 [TBL] [Abstract][Full Text] [Related]
10. [A new attempt at estimating the activity of the rheumatic process: the influence of urine on the reduction of the molybdates]. Krzymień H Pol Tyg Lek; 1970 Jun; 25(25):916-8. PubMed ID: 5310709 [No Abstract] [Full Text] [Related]
11. Recalcification time in breast disease. Sofia CA; Spillert CR; Pastena JA; Lazaro EJ J Natl Med Assoc; 1988 Nov; 80(11):1214-6. PubMed ID: 3249326 [TBL] [Abstract][Full Text] [Related]
12. Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses. Chen Y; Sun J; Yang Y; Huang Y; Liu G Clin Rheumatol; 2016 Jan; 35(1):1-18. PubMed ID: 26573205 [TBL] [Abstract][Full Text] [Related]
13. Urinary tissue factor levels in patients with bladder and prostate cancer. Lwaleed BA; Francis JL; Chisholm M Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179 [TBL] [Abstract][Full Text] [Related]
14. Urinary tissue factor levels in transitional cell carcinoma of the bladder. Adamson AS; Francis JL; Roath OS; Witherow RO; Snell ME J Urol; 1992 Aug; 148(2 Pt 1):449-52. PubMed ID: 1378910 [TBL] [Abstract][Full Text] [Related]